Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Similarly, the levels of vitamins including 4‐oxo‐retinoic acid, 24,25‐dihydroxy vitamin D, vitamin D2 3‐glucuronide, vitamin K 1 2,3‐epoxide, and pyridoxine were significantly higher in GeHQDs‐treated cells compared to activated immune cells (Figure 4e,f).

Source: GeHQDs Treatment Shifts Cellular Metabolism Toward Treg Phenotype. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo

Study design awaiting verification · Advanced Functional Materials · 2026

Original publication title

Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo

Abhay Srivastava; Alireza Rafieerad; Weiang Yan; Keshav Narayan Alagarsamy; Qingdong Guan; Leena Regi Saleth; Michel Aliani; Sanjiv Dhingra

© 2026 The Author(s). Advanced Functional Materials published by Wiley‐VCH GmbH

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases. Metabolic changes in immune cells direct the phenotype and function of the host immune system. Therefore, next‐generation immunomodulatory biomaterials should be designed to target metabolic pathways and trigger specific changes in immune cells to direct their fate toward an anti‐inflammatory phenotype. The current study reports the fabrication and first application of germanane quantum dots (GeHQDs) to modulate inflammation in cell culture and in vivo mouse model.

Using rational design and synthesis strategies, our GeHQDs leverage the intrinsic anti‐inflammatory properties of germanane to provide a novel nanoplatform to trigger metabolic reprogramming of immune cells toward an anti‐inflammatory phenotype. These GeHQDs are spontaneously uptaken into the immune cells and trigger a switch in their phenotype toward regulatory T (Treg) cells. Metabolomic analysis suggested a downregulation in glycolytic flux and upregulation in fatty acid oxidation with an increase in mitochondrial respiration in the GeHQDs‐treated group, which is a typical signature of Treg cells.

In an in vivo mouse model of systemic inflammation, GeHQDs treatment upregulated the circulating Treg cell number, improved the metabolomic profile and downregulated inflammation. The current study presents a new paradigm in targeting inflammatory diseases by modulating immune cell metabolism using next‐generation nanomaterials.

Authors’ abstract

ABSTRACT

Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases. Metabolic changes in immune cells direct the phenotype and function of the host immune system. Therefore, next‐generation immunomodulatory biomaterials should be designed to target metabolic pathways and trigger specific changes in immune cells to direct their fate toward an anti‐inflammatory phenotype. The current study reports the fabrication and first application of germanane quantum dots (GeHQDs) to modulate inflammation in cell culture and in vivo mouse model.

Using rational design and synthesis strategies, our GeHQDs leverage the intrinsic anti‐inflammatory properties of germanane to provide a novel nanoplatform to trigger metabolic reprogramming of immune cells toward an anti‐inflammatory phenotype. These GeHQDs are spontaneously uptaken into the immune cells and trigger a switch in their phenotype toward regulatory T (Treg) cells. Metabolomic analysis suggested a downregulation in glycolytic flux and upregulation in fatty acid oxidation with an increase in mitochondrial respiration in the GeHQDs‐treated group, which is a typical signature of Treg cells.

In an in vivo mouse model of systemic inflammation, GeHQDs treatment upregulated the circulating Treg cell number, improved the metabolomic profile and downregulated inflammation. The current study presents a new paradigm in targeting inflammatory diseases by modulating immune cell metabolism using next‐generation nanomaterials.

Publication and source details

Original title: Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo

Abhay Srivastava; Alireza Rafieerad; Weiang Yan; Keshav Narayan Alagarsamy; Qingdong Guan; Leena Regi Saleth; Michel Aliani; Sanjiv Dhingra

Advanced Functional Materials · 2026

© 2026 The Author(s). Advanced Functional Materials published by Wiley‐VCH GmbHhttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Natural Sciences and Engineering Research Council of Canada10.13039/501100000038 Canadian Institutes of Health Research10.13039/501100000024

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:30:16.144176+00:00

DOI: 10.1002/adfm.202521057 · PMC13494919